The abstract is read at the publisher; the summary is JClub's.
Dual blockade of LIGHT and OXPHOS in a Th2-low murine asthma model on the Il4rα -/- background reverses all MGA features back to baseline and increases Treg numbers.
- Why it matters: Mixed granulocytic asthma is steroid-resistant and linked to Th17/neutrophilic inflammation and airway remodeling, but how Th17 differentiation and remodeling are coordinated is unclear.
- What they did: LIGHT (aka TNFSF14) and OXPHOS are enriched in human MGA and upregulated in the Il4rα -/- Th2-low mouse model; OXPHOS was tested in vitro and in vivo, and LIGHT and OXPHOS were blocked singly and together.
- The result: OXPHOS promotes Th17 metabolic reprogramming that sustains survival under steroid treatment and drives LIGHT production; LIGHT controls remodeling via an MMP9-dependent TGFβ pathway, while combined LIGHT antagonism plus OXPHOS inhibition reverses MGA features and increases Treg cells.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.